Matches in SemOpenAlex for { <https://semopenalex.org/work/W1963856181> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W1963856181 endingPage "A138" @default.
- W1963856181 startingPage "A137.2" @default.
- W1963856181 abstract "When P2Y<sub>12</sub> receptors on platelets are blocked by commonly used anti-platelet drugs such as clopidogrel and prasugrel, the inhibitory brake on adenylate cyclase (AC) activity is lifted and the anti-platelet effects of prostacyclin (PGI<sub>2</sub>) and other agents that activate platelet AC are synergistically enhanced. We have recently demonstrated that blockade of the P2Y<sub>12</sub> receptor also enhances the anti-platelet effect of nitric oxide (NO). The aim of this study was to study the interaction between PGI<sub>2</sub>, NO and P2Y<sub>12</sub> receptor inhibition on platelet aggregation and to determine pharmacologically, using isobolographic analysis, if this interaction constitutes a true synergy or simply an additive effect. <h3>Methods</h3> Blood was collected by venepuncture into 0.32% trisodium citrate. Platelet rich plasma (PRP) was isolated by centrifugation and either tested directly or further washed with Tyrode’s-Hepes buffer. The PRP or washed platelets (WP) were incubated with the P2Y<sub>12</sub> inhibitor prasugrel active metabolite (PAM; 3 µM) or vehicle (0.5% DMSO) for 30 min followed by 1 min incubation with the NO donor DEA/NONOate (10 nM–1 mM) and/or PGI<sub>2</sub> (0.2 nM–100 nM) and/or vehicle (0.01M NaOH). WP platelet aggregation to thrombin (1U/ml) was measured by 96-well aggregometry and PRP platelet aggregation to TRAP-6 (Thrombin Receptor Activating Peptide-6, 30 µM) or collagen (30 µg/ml) was measured by light transmission aggregometry (LTA). Isobolograms were constructed by plotting the IC<sub>50</sub> values for DEA-NONOate and PGI<sub>2</sub> in vehicle or PAM treated WP. Data represents mean±SEM % final platelet aggregation from 4–5 healthy volunteers. <h3>Results</h3> Thrombin (1U/ml), TRAP-6 (30 µM) or collagen (30 µg/ml) all produced robust aggregation responses in WP and PRP respectively which was largely unaffected by the addition of 10nM DEA-NONOate and 4nM PGI<sub>2</sub> or 3 µM PAM. However, the combination of all three (NO, PGI<sub>2</sub> and PAM) resulted in almost complete inhibition of platelet aggregation. Isobolographic analysis of the data showed that the interaction between DEA/NONOate, PGI<sub>2</sub> and PAM in WP was strongly synergistic (isoboles curved away from the predicted linear line for an additive relationship). <h3>Conclusions</h3> These data confirm that activation of platelet P2Y<sub>12</sub> receptors by secreted ADP limits the anti-platelet effects of both NO and PGI<sub>2,</sub> suggesting that P2Y<sub>12</sub> activation may be an important mechanism for haemostasis. In addition, we have demonstrated that the interaction between P2Y<sub>12</sub> receptors and vascular mediators is strongly synergistic. Potentiation of the effects of endogenous NO and PGI<sub>2</sub> may represent an important mechanism for how P2Y<sub>12</sub> inhibitors produce anti-thrombotic protection." @default.
- W1963856181 created "2016-06-24" @default.
- W1963856181 creator A5002943978 @default.
- W1963856181 creator A5007245592 @default.
- W1963856181 creator A5044468329 @default.
- W1963856181 creator A5049732997 @default.
- W1963856181 date "2013-05-01" @default.
- W1963856181 modified "2023-09-25" @default.
- W1963856181 title "261 P2Y12 INHIBITION GREATLY POTENTIATES THE ANTI-PLATELET EFFECTS OF PROSTACYCLIN AND NITRIC OXIDE" @default.
- W1963856181 doi "https://doi.org/10.1136/heartjnl-2013-304019.261" @default.
- W1963856181 hasPublicationYear "2013" @default.
- W1963856181 type Work @default.
- W1963856181 sameAs 1963856181 @default.
- W1963856181 citedByCount "1" @default.
- W1963856181 countsByYear W19638561812014 @default.
- W1963856181 crossrefType "journal-article" @default.
- W1963856181 hasAuthorship W1963856181A5002943978 @default.
- W1963856181 hasAuthorship W1963856181A5007245592 @default.
- W1963856181 hasAuthorship W1963856181A5044468329 @default.
- W1963856181 hasAuthorship W1963856181A5049732997 @default.
- W1963856181 hasBestOaLocation W19638561811 @default.
- W1963856181 hasConcept C126322002 @default.
- W1963856181 hasConcept C170493617 @default.
- W1963856181 hasConcept C185592680 @default.
- W1963856181 hasConcept C2776785769 @default.
- W1963856181 hasConcept C2777028646 @default.
- W1963856181 hasConcept C2777292125 @default.
- W1963856181 hasConcept C2777628954 @default.
- W1963856181 hasConcept C2777849778 @default.
- W1963856181 hasConcept C2779837110 @default.
- W1963856181 hasConcept C2780076745 @default.
- W1963856181 hasConcept C2781128415 @default.
- W1963856181 hasConcept C2993802102 @default.
- W1963856181 hasConcept C3018697912 @default.
- W1963856181 hasConcept C49059817 @default.
- W1963856181 hasConcept C519581460 @default.
- W1963856181 hasConcept C71924100 @default.
- W1963856181 hasConcept C89560881 @default.
- W1963856181 hasConcept C98274493 @default.
- W1963856181 hasConceptScore W1963856181C126322002 @default.
- W1963856181 hasConceptScore W1963856181C170493617 @default.
- W1963856181 hasConceptScore W1963856181C185592680 @default.
- W1963856181 hasConceptScore W1963856181C2776785769 @default.
- W1963856181 hasConceptScore W1963856181C2777028646 @default.
- W1963856181 hasConceptScore W1963856181C2777292125 @default.
- W1963856181 hasConceptScore W1963856181C2777628954 @default.
- W1963856181 hasConceptScore W1963856181C2777849778 @default.
- W1963856181 hasConceptScore W1963856181C2779837110 @default.
- W1963856181 hasConceptScore W1963856181C2780076745 @default.
- W1963856181 hasConceptScore W1963856181C2781128415 @default.
- W1963856181 hasConceptScore W1963856181C2993802102 @default.
- W1963856181 hasConceptScore W1963856181C3018697912 @default.
- W1963856181 hasConceptScore W1963856181C49059817 @default.
- W1963856181 hasConceptScore W1963856181C519581460 @default.
- W1963856181 hasConceptScore W1963856181C71924100 @default.
- W1963856181 hasConceptScore W1963856181C89560881 @default.
- W1963856181 hasConceptScore W1963856181C98274493 @default.
- W1963856181 hasIssue "suppl 2" @default.
- W1963856181 hasLocation W19638561811 @default.
- W1963856181 hasOpenAccess W1963856181 @default.
- W1963856181 hasPrimaryLocation W19638561811 @default.
- W1963856181 hasRelatedWork W1474881703 @default.
- W1963856181 hasRelatedWork W1693250771 @default.
- W1963856181 hasRelatedWork W1963856181 @default.
- W1963856181 hasRelatedWork W2088369540 @default.
- W1963856181 hasRelatedWork W2122863909 @default.
- W1963856181 hasRelatedWork W2414570195 @default.
- W1963856181 hasRelatedWork W2492085083 @default.
- W1963856181 hasRelatedWork W2592711088 @default.
- W1963856181 hasRelatedWork W2739317526 @default.
- W1963856181 hasRelatedWork W3144099496 @default.
- W1963856181 hasVolume "99" @default.
- W1963856181 isParatext "false" @default.
- W1963856181 isRetracted "false" @default.
- W1963856181 magId "1963856181" @default.
- W1963856181 workType "article" @default.